🔎 Trials Near Me

Beranda › Neuroblastoma › New York › New York City

Uji klinis Neuroblastoma di New York City, NY

10 studi untuk Neuroblastoma mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Menerima pesertaStudi observasional
  • Memorial Sloan Kettering Cancer Center, New York
Semua usia · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT00588068

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Menerima pesertaFase 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Hingga usia 30 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06172296

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Menerima pesertaFase 2Sukarelawan sehat diterima
  • Memorial Sloan Kettering Cancer Center, New York
Semua usia · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT04936529

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Menerima pesertaFase 1/2
  • Memorial Sloan Kettering Cancer Center ( Site 1010), New York
6 Months – 25 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06395103

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center, New York
18 Months – 19 Years · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT06528496

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Menerima pesertaFase 3
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
365 Days – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Menerima pesertaFase 1/2
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

Menerima pesertaFase 1/2
  • Memorial Sloan Kettering Kids, New York
Usia 2 hingga 21 · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05642455

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Semua usia · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT06057948

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center, New York
Usia 1 ke atas · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT00107289

Uji klinis Neuroblastoma di kota lain

Studi lain di New York City

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.